OOppenheimer NNVIDIA · NVDA

Oppenheimer Lifts Nvidia’s PT to $265

Nov 13, 2025· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$265
Previous
$225
Implied upside
+37%

Oppenheimer analyst Rick Schafer raised on November 13, 2025, the price target on Nvidia to $265 (from $225), while maintaining an ‘Outperform’ rating on the stock.

NVDA reports earnings Wednesday (11/19).

We see upside to consensus F3Q (Oct.) sales/EPS $54.7B/$1.25 and F4Q (Jan.) $61.5B/$1.42 led by new GB300 Ultra. CSP/hyperscalers continue to upside capex reflecting insatiable AI appetite.

NVDA rack-scale NVL72 remains AI’s go-to performance/watt leader. NVL72 supply remains tight as backlog grows.

At GTC DC two weeks ago, Founder/CEO Jensen Huang highlighted cumulative Blackwell/Rubin revenues of $500B by end CY26 ($350B balance).

Exponential growth drivers including reasoning and agentic AI creating an adoption flywheel. China, >$50B opportunity, remains out of the model for now.

NVDA overall TAM $4T ($2T CSP, $1.5T sovereign, $500B enterprise).

Power remains an omnipresent bottleneck. NVDA remains best positioned to win in AI.

Reiterate Outperform. Target to $265 (from $225).”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.